Gan & Lee Pharmaceuticals Co Ltd is a company engaged in research and development, production and sales of insulin and related products. The Company’s main products are insulin preparations and insulin dry powder, including Changxiulin recombinant insulin glargine injection and Suxiulin recombinant insulin lispro injection. It is also involved in the development and sales of a type of insulin pen called Xiulin Pen and the components. The Company provides early-stage franchising services by authorizing other companies to sell its insulin injections. The Company sells its products to both domestic and international markets, including Mexico and the Middle East.